Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease

Disease Markers

Volumn 27, Issue 6, 2009, Pages 287-294

  Shakoori, Tania Ahmed ^a   Sin, Don D ^b   Ghafoor, Farkhanda ^a   Bashir, Saira ^a   Bokhari, S Nazim Hussain ^a  

^a SZMC   (Pakistan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

COPD; Diagnostic; Exacerbations; Serum biomarker; Surfactant protein D

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; STEROID; SURFACTANT PROTEIN D;

ADULT; ANALYSIS OF COVARIANCE; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOASSAY; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 77249166048     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/759304     Document Type: Article

References (28)

1. K.F. Rabe, S. Hurd, A. Anzueto et al., Global Strategy for the Diagnosis, Management, and Prevention of COPD - 2006 Update, Am J Respir Crit Care Med 176 (2007), 532-555.
2. D.D. Sin, P.S. Pahlvan and S.F.P. Man, Review: Surfactant protein D: A lung specific biomarker in COPD? Ther Adv Resp Dis 2(2) (2008), 65-74.
3. R.J. Mason, K. Greene and D.R. Voelker, Surfactant protein A and surfactant protein D in health and disease, Am J Physiol 275(1 Pt 1) (1998), L1-L13.
4. N. Palaniyar, J. Nadesalingam, H. Clark et al., Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin, J Biol Chem 279(31) (2004), 32728-32736.
5. N. Palaniyar, H. Clark, J. Nadesalingam et al., Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo, Ann N Y Acad Sci 1010 (2003), 471-475.
6. D.D. Sin, R. Leung, W.Q. Gan et al., Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study, BMC Pulm Med 7 (2007), 1.
7. S. Burge and J.A.Wedzicha, COPD exacerbations: definitions and classifications, Eur Respir J 21(41) (2003), S46-S53.
8. A.M. Pastva, J.R. Wright and K.L. Williams, Immunomodulatory Roles of Surfactant Proteins A and D-Implications in Lung Disease, Proc Am Thorac Soc 4 (2007), 252-257.
9. R.W. Vandivier, C.A. Ogden, V.A. Fadok et al., Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex, J Immunol 169(7) (2002), 3978-3986.
10. G. Cheng, T. Ueda, T. Numao et al., Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma, Eur Respir J 16 (2000), 831-835.
11. T.L. Noah, C. Paula, P.C. Murphy et al., Bronchoalveolar Lavage Fluid Surfactant Protein-A and Surfactant Protein-D Are Inversely Related to Inflammation in Early Cystic Fibrosis, Am J Respir Crit Care Med 168(6) (2003), 685-691.
12. Y. Honda, H. Takahashi, Y. Kuroki et al., Decreased Contents of Surfactant Proteins A and D in BAL Fluids of Healthy Smokers, Chest 109 (1996), 1006-1009.
13. M.W. Sims, R.M. Tal-Singer and S. Kierstein, Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study, Respir Res 9 (2008), 13.
14. A. Mutti, M. Corradi, M. Goldoni et al., Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma, Chest 129(5) (2006), 1288-1297.
15. M. Fujita, J.M. Shannon, H. Ouchi et al., Serum surfactant protein D is increased in acute and chronic inflammation in mice, Cytokine 31(1) (2005), 25-33.
16. D.D. Sin, S.F. Man, D.D. Marciniuk et al., The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med 177(11) (2008), 1207-1214.
17. D.A. Lomas, E.K. Silverman, L.D. Edwards et al., Surfactant proteinDis steroid sensitive and associated with exacerbations of COPD, Eur Resp J 34(1) (2009), 95-102.
18. N. Hirama, Y. Shibata, K. Otake et al., Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema, Respirology 12(2) (2007), 191-201.
19. G.R. Mason, A.M. Peters, E. Bagdades et al., Evaluation of pulmonary alveolar epithelial integrity by the detection of restriction to diffusion of hydrophilic solutes of different molecular sizes, Clin Sci (Lond) 100(3) (2007), 231-236.
20. G.R. Mason, J.M. Uszler, R.M. Effros et al., Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking, Chest 83(1) (1983), 6-11.
21. K. Heidinger, I.R. Konig, A. Bohnert et al., Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong ev idence that serum levels of surfactant protein-D (SP-D) are genetically influenced, Immunogenetics 57(1-2) (2005), 1-7.
22. G.L. Sørensen, J.B. Hjelmborg, K.O. Kyvik et al., Genetic and environmental influences of surfactant protein D serum levels, Am J Physiol Lung Cell Mol Physiol 290(5) (2006), L1010-L1017.
23. H. Kobayashi, S. Kanoh and K. Motoyoshi, Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking, Biomarkers 13(4) (2008), 385-392.
24. S. Ohlmeier, M. Vuolanto, T. Toljamo et al., Proteomics of human lung tissue identifies surfactant protein Aas a marker of chronic obstructive pulmonary disease, J Proteome Res 7(12) (2008), 5125-5132.
25. J.R. Hurst, G.C. Donaldson, W.R. Perera et al., Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med 174 (2006), 867-874.
26. S. Bozinovski, A. Hutchinson, M. Thompson et al., Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease, Am J Respir Crit Care Med 177(3) (2008), 269-278.
27. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser et al., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet 363(9420) (2004), 1555-1556.
28. B. M̈uller, N. Morgenthaler, D. Stolz et al., Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections, Eur J Clin Invest 37(2) (2007), 145-152.